Depressive symptoms and course are associated with early relapse in opioid-dependent individuals treated with extended-release naltrexone but not buprenorphine-naloxone

Citation: Hammond, C.J., Pollack, A., Miller, L., Park, G., Kady, A., Wenzel, K., & Fishman, M. (2019, September). Depressive symptoms and course are associated with early relapse in opioid-dependent individuals treated with extended-release naltrexone but not buprenorphine-naloxone [Poster presentation]. Presented at the National Network of Depression Centers (NNDC) 11th Annual Conference, Virtual.